Keywords: Germany, Health reform. AMNOG, Prices, Eli Lilly, Collaborative relationships

Lilly CEO warns that Germany’s health reforms are harming innovation

Article | 11 July 2011

Print This

Speaking to the Federation of German Industries Conference in Germany last week, John Lechleiter, chairman, president and chief executive of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in